Cor­rect­ed: Bench­Sci rais­es $70M Se­ries D for drug dis­cov­ery soft­ware; Zen­tal­is touts PhIb ovar­i­an can­cer da­ta

Cana­da’s Bench­Sci has raised $70 mil­lion in a Se­ries D round de­signed to scale its AI drug dis­cov­ery plat­form for sci­en­tists work­ing in pre­clin­i­cal re­search …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER